Publications by authors named "H U Ghori"
Article Synopsis
- The study investigates the link between high HbA1c levels and the severity of coronary artery disease (CAD) in patients diagnosed with acute coronary syndrome (ACS).
- It involved 120 patients with different types of ACS who were also diagnosed with diabetes, measuring their HbA1c levels and performing coronary angiography to assess CAD severity.
- Results showed that higher HbA1c levels (especially above 10.5%) were associated with more severe forms of CAD, suggesting the need for optimal glycemic control to reduce cardiovascular risks.
Background: Proximal ulna fracture-dislocations are challenging injuries with a myriad of existing classification systems. The Coronoid, proximal Ulna, Radius, and Ligaments classification (CURL) is a simple framework designed to focus attention on the key components affecting outcome and guide surgical management. This study evaluates interobserver and intraobserver reliability of this new classification.
View Article and Find Full Text PDFBackground: The treatment of locally advanced head and neck carcinoma has been a combination of chemotherapy and radiation. The higher incidences of recurrence and metastasis warrant the search for an alternative therapy for better patient outcomes. This study was designed to evaluate the effect of gefitinib in conjunction with concurrent chemoradiation in locally advanced stages III and IV head and neck cancer.
View Article and Find Full Text PDFBackground: Metastatic disease of bone is a common complication of most of the advanced malignancies. The majority of patients with bone metastases (BM) experience pain during their disease course and pain control can significantly improve their quality of life. Radiotherapy (RT) is an important modality in the management of BM and different schedules are followed worldwide.
View Article and Find Full Text PDFAim: In this paper, we present a prospective observational study, which determines the incidence of bone metastases and its correlation with hormonal receptors (estrogen receptor [ER]/progesterone receptor [PR]) and human epidermal growth factor receptor 2 (HER2) in breast cancer.
Materials And Methods: From October of 2015 to July 2017, 262 patients were eligible for the study, of which 98 patients presented/developed bone metastases. ER/PR and HER2 receptor status were determined, and bone scintigraphy with a technetium-99 m was carried out on each patient during the study.